GGrantIndex
Sort

78,016 grants matching breast cancer

Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain

$475,250
Cyrus M Ghajar · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Addressing Urban Rural Disparities in Cancer: The Case for Registry Expansion

$475,193
Cathy J. Bradley · University Of Colorado Denver · R01 · FY2020 · CA

Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis

$475,165
Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA

University of Michigan WRHR Career Development Program

$475,115
Timothy Rb Johnson · University Of Michigan At Ann Arbor · K12 · FY2011 · HD

University of Michigan WRHR Career Development Program

$475,115
Timothy Rb Johnson · University Of Michigan At Ann Arbor · K12 · FY2010 · HD

Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance

$475,049
Franziska Michor · Dana-Farber Cancer Inst · R01 · FY2012 · CA

Understanding the influence of Mitochondrial DNA haplotypes on breast aging and cancer

$475,041
Doris A Germain · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG

Spatially-resolved proteome mapping of senescent cells and their tissue microenvironment at single-cell resolution

$475,000
Ljiljana Pasa-Tolic · Battelle Pacific Northwest Laboratories · UG3 · FY2022 · CA

Spatially-resolved proteome mapping of senescent cells and their tissue microenvironment at single-cell resolution

$474,999
Ljiljana Pasa-Tolic · Battelle Pacific Northwest Laboratories · UG3 · FY2023 · CA

Metabolic alterations in advanced Breast Cancer and response to systemic therapy.

$474,987
David Mark Hockenbery · Fred Hutchinson Cancer Research Center · P50 · FY2012 · CA

Two Compartment Models to Improve Brain Tumor Therapy

$474,976
Edward A Neuwelt · Oregon Health & Science University · R01 · FY2016 · CA

Risk Factors for Sepsis in the Community

$474,942
Henry E Wang · University Of Alabama At Birmingham · R01 · FY2015 · NR

hiPSC-Cardiomyocytes to Screen Variants Predictive of Doxorubicin Cardiotoxicity

$474,934
Daniel Bernstein · Stanford University · R33 · FY2017 · HL

Immune biological differences between Triple Negative Breast Cancer in African American and non-African American women and potential immunotherapy opportunities to improve treatment outcome

$474,931
Lajos Pusztai · Yale University · R01 · FY2020 · CA

Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma

$474,928
David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma

$474,928
David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Molecular and Genetic Determinants of Invasion in HNSCC

$474,881
Cun-Yu Wang · University Of California Los Angeles · R01 · FY2010 · DE

DEVELOPMENTAL FUNDS

$474,877
Paul A Bunn · University Of Colorado Denver · P30 · FY2015 · CA

CANCER IN THE JERUSALEM PERINATAL STUDY COHORT

$474,873
New York University School Of Medicine · R01 · FY2000 · CA

Novel predictors of survival among breast cancer patients with/without HIV in South Africa

$474,837
Maureen Joffe · Wits Health Consortium (Pty), Ltd · R01 · FY2021 · CA

Role of BMP and FGF signaling during limb development

$474,836
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance

$474,833
Joe W. Gray · Oregon Health & Science University · U54 · FY2017 · CA

CBT +/- Modafinil for Insomnia and Fatigue following Chemotherapy

$474,827
Gary R Morrow · University Of Rochester · R01 · FY2008 · CA

Defining role of FANCA in genome instability

$474,789
Yanbin Zhang · University Of Miami School Of Medicine · R56 · FY2020 · HL

Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy

$474,760
Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2010 · CA